Keywords
Last Name
Institution

Allen P. Kaplan

Title
InstitutionMedical University of South Carolina
DepartmentPulmonary
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Kaplan AP. Preventing Anaphylaxis Fatalities: Should We Target Bradykinin? J Allergy Clin Immunol. 2020 Feb 06. PMID: 32035986.
      View in: PubMed
    2. Larrauri B, Hester CG, Jiang H, Miletic VD, Malbran A, Bork K, Kaplan A, Frank M. sgp120 and the contact system in hereditary angioedema: A diagnostic tool in HAE with normal C1 inhibitor. Mol Immunol. 2020 Jan 16; 119:27-34. PMID: 31955064.
      View in: PubMed
    3. Ivanov I, Verhamme IM, Sun MF, Mohammed B, Cheng Q, Matafonov A, Dickeson SK, Joseph K, Kaplan AP, Gailani D. Protease Activity in Single-Chain Prekallikrein. Blood. 2019 Dec 04. PMID: 31800958.
      View in: PubMed
    4. Kaplan AP, Pawaskar D, Chiao J. C1 Inhibitor Activity and Angioedema Attacks in Patients with Hereditary Angioedema. J Allergy Clin Immunol Pract. 2019 Oct 23. PMID: 31655295.
      View in: PubMed
    5. Schmaier AH, Emsley J, Feener EP, Gailani D, Govers-Riemslag JWP, Kaplan AP, Maas C, Morrissey JH, Renné T, Sidelmann JJ, Meijers JCM. Nomenclature of factor XI and the contact system. J Thromb Haemost. 2019 Dec; 17(12):2216-2219. PMID: 31410964.
      View in: PubMed
    6. Kaplan AP. Treatment of urticaria: a clinical and mechanistic approach. Curr Opin Allergy Clin Immunol. 2019 Aug; 19(4):387-392. PMID: 31246664.
      View in: PubMed
    7. Kaplan AP. Basophil histamine release in patients with chronic spontaneous urticaria: Optimize or minimize. J Allergy Clin Immunol. 2019 Aug; 144(2):622-623. PMID: 31202669.
      View in: PubMed
    8. Gómez RM, Jares E, Borges MS, Baiardini I, Canonica GW, Passalacqua G, Kaplan A, Latour P, Costa E, Dias G, Lavrut J. Latin American chronic urticaria registry (CUR) contribution to the understanding and knowledge of the disease in the region. World Allergy Organ J. 2019; 12(6):100042. PMID: 31237575.
      View in: PubMed
    9. Saini SS, Kaplan AP. Chronic Spontaneous Urticaria: The Devil's Itch. J Allergy Clin Immunol Pract. 2018 Jul - Aug; 6(4):1097-1106. PMID: 30033911.
      View in: PubMed
    10. Kaplan AP. Diagnosis, pathogenesis, and treatment of chronic spontaneous urticaria. Allergy Asthma Proc. 2018 May 01; 39(3):184-190. PMID: 29669665.
      View in: PubMed
    11. Kaplan AP, Maas C. The Search for Biomarkers in Hereditary Angioedema. Front Med (Lausanne). 2017; 4:206. PMID: 29214154.
      View in: PubMed
    12. Maurer M, Kaplan A, Rosén K, Holden M, Iqbal A, Trzaskoma BL, Yang M, Casale TB. The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria. J Allergy Clin Immunol. 2018 03; 141(3):1138-1139.e7. PMID: 29132956.
      View in: PubMed
    13. Kaplan AP. Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations. Allergy Asthma Immunol Res. 2017 Nov; 9(6):477-482. PMID: 28913986.
      View in: PubMed
    14. Casale TB, Win PH, Bernstein JA, Rosén K, Holden M, Iqbal A, Trzaskoma BL, Yang M, Antonova EN, Murphy T, Scarupa MD, Sofen H, Kaplan A. Omalizumab response in patients with chronic idiopathic urticaria: Insights from the XTEND-CIU study. J Am Acad Dermatol. 2018 04; 78(4):793-795. PMID: 29037993.
      View in: PubMed
    15. Kaplan AP, Joseph K. Pathogenesis of Hereditary Angioedema: The Role of the Bradykinin-Forming Cascade. Immunol Allergy Clin North Am. 2017 08; 37(3):513-525. PMID: 28687106.
      View in: PubMed
    16. Finlay AY, Kaplan AP, Beck LA, Antonova EN, Balp MM, Zazzali J, Khalil S, Maurer M. Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria. J Eur Acad Dermatol Venereol. 2017 Oct; 31(10):1715-1721. PMID: 28573683.
      View in: PubMed
    17. Gómez RM, Jares E, Canonica GW, Baiardini I, Passalacqua G, Sánchez Borges M, Kaplan AP, Baena-Cagnani CE. Why a registry of Chronic Urticaria (CUR) is needed. World Allergy Organ J. 2017; 10(1):16. PMID: 28546849.
      View in: PubMed
    18. Zazzali JL, Kaplan A, Maurer M, Raimundo K, Trzaskoma B, Antonova EN, Rosén KE. Importance of angioedema-free days in patients with chronic idiopathic or spontaneous urticaria. Ann Allergy Asthma Immunol. 2017 04; 118(4):524. PMID: 28390589.
      View in: PubMed
    19. Joseph K, Constantino-Silva RN, Grumach AS, Feldweg A, Wright L, Frank N, Vuzman D, Sharma R, Suffritti C, Cicardi M, Varga L, Farkas H, Bork K, Kaplan AP. Reply. J Allergy Clin Immunol. 2017 05; 139(5):1720-1721. PMID: 28318557.
      View in: PubMed
    20. Kaplan AP, Giménez-Arnau AM, Saini SS. Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria. Allergy. 2017 Apr; 72(4):519-533. PMID: 27861988.
      View in: PubMed
    21. Joseph K, Tholanikunnel BG, Kaplan AP. Cytokine and estrogen stimulation of endothelial cells augments activation of the prekallikrein-high molecular weight kininogen complex: Implications for hereditary angioedema. J Allergy Clin Immunol. 2017 Jul; 140(1):170-176. PMID: 27826093.
      View in: PubMed
    22. Ghebrehiwet B, Kaplan AP, Joseph K, Peerschke EI. The complement and contact activation systems: partnership in pathogenesis beyond angioedema. Immunol Rev. 2016 11; 274(1):281-289. PMID: 27782339.
      View in: PubMed
    23. Kaplan AP, Joseph K. Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent. Clin Rev Allergy Immunol. 2016 Oct; 51(2):207-15. PMID: 27273087.
      View in: PubMed
    24. Kaplan AP. Fibrinolysis and bradykinin formation: From in vitro observations to human disease in "just" 45 years. J Allergy Clin Immunol. 2016 11; 138(5):1424-1425. PMID: 27516215.
      View in: PubMed
    25. Zazzali JL, Kaplan A, Maurer M, Raimundo K, Trzaskoma B, Solari PG, Antonova E, Mendelson M, Rosén KE. Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies. Ann Allergy Asthma Immunol. 2016 10; 117(4):370-377.e1. PMID: 27424128.
      View in: PubMed
    26. Kaplan AP, Greenberger PA, Geller M. Vibratory Urticaria and ADGRE2. N Engl J Med. 2016 07 07; 375(1):94-5. PMID: 27406366.
      View in: PubMed
    27. Sebaaly J, Bowers L, Mazur J, Kotloff R, Olmsted BR, Kaplan A, Strange C. Rapid oral desensitization to sirolimus in a patient with lymphangioleiomyomatosis. J Allergy Clin Immunol Pract. 2016 Mar-Apr; 4(2):352-3. PMID: 26725158.
      View in: PubMed
    28. Kaplan A, Ferrer M, Bernstein JA, Antonova E, Trzaskoma B, Raimundo K, Rosén K, Omachi TA, Khalil S, Zazzali JL. Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria. J Allergy Clin Immunol. 2016 Feb; 137(2):474-81. PMID: 26483177.
      View in: PubMed
    29. Joseph K, Tholanikunnel BG, Wolf B, Bork K, Kaplan AP. Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels. J Allergy Clin Immunol. 2016 06; 137(6):1822-1829.e1. PMID: 26395818.
      View in: PubMed
    30. Kaplan AP, Joseph K, Saini SS. How omalizumab came to be studied as a therapy for chronic spontaneous/idiopathic urticaria. J Allergy Clin Immunol Pract. 2015 Jul-Aug; 3(4):648. PMID: 26164583.
      View in: PubMed
    31. Casale TB, Bernstein JA, Maurer M, Saini SS, Trzaskoma B, Chen H, Grattan CE, Gimenéz-Arnau A, Kaplan AP, Rosén K. Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy. J Allergy Clin Immunol Pract. 2015 Sep-Oct; 3(5):743-50.e1. PMID: 26054553.
      View in: PubMed
    32. Fukuda Y, Fukui T, Hikichi C, Ishikawa T, Murate K, Adachi T, Imai H, Fukuhara K, Ueda A, Kaplan AP, Mutoh T. Neurotropin promotes NGF signaling through interaction of GM1 ganglioside with Trk neurotrophin receptor in PC12 cells. Brain Res. 2015 Jan 30; 1596:13-21. PMID: 25454796.
      View in: PubMed
    33. Crowther M, Bauer KA, Kaplan AP. The thrombogenicity of C1 esterase inhibitor (human): review of the evidence. Allergy Asthma Proc. 2014 Nov-Dec; 35(6):444-53. PMID: 25584911.
      View in: PubMed
    34. Joseph K, Bains S, Tholanikunnel BG, Bygum A, Aabom A, Koch C, Farkas H, Varga L, Ghebrehiwet B, Kaplan AP. A novel assay to diagnose hereditary angioedema utilizing inhibition of bradykinin-forming enzymes. Allergy. 2015 Jan; 70(1):115-9. PMID: 25186184.
      View in: PubMed
    35. Kaplan AP, Popov TA. Biologic agents and the therapy of chronic spontaneous urticaria. Curr Opin Allergy Clin Immunol. 2014 Aug; 14(4):347-53. PMID: 24936849.
      View in: PubMed
    36. Kaplan AP. Bradykinin-mediated diseases. Chem Immunol Allergy. 2014; 100:140-7. PMID: 24925394.
      View in: PubMed
    37. Kaplan AP. The bradykinin-forming cascade: a historical perspective. Chem Immunol Allergy. 2014; 100:205-13. PMID: 24925400.
      View in: PubMed
    38. Cicardi M, Aberer W, Banerji A, Bas M, Bernstein JA, Bork K, Caballero T, Farkas H, Grumach A, Kaplan AP, Riedl MA, Triggiani M, Zanichelli A, Zuraw B. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014 May; 69(5):602-16. PMID: 24673465.
      View in: PubMed
    39. Kaplan AP. Therapy of chronic urticaria: a simple, modern approach. Ann Allergy Asthma Immunol. 2014 May; 112(5):419-25. PMID: 24656924.
      View in: PubMed
    40. Viegas LP, Ferreira MB, Kaplan AP. The maddening itch: an approach to chronic urticaria. J Investig Allergol Clin Immunol. 2014; 24(1):1-5. PMID: 24765875.
      View in: PubMed
    41. Kaplan AP, Joseph K. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway. Adv Immunol. 2014; 121:41-89. PMID: 24388213.
      View in: PubMed
    42. Magerl M, Bader M, Gompel A, Joseph K, Kaplan AP, Kojda G, Renné T, Wirth M, Maurer M, Church MK. Bradykinin in health and disease: proceedings of the Bradykinin Symposium 2012, Berlin 23-24 August 2012. Inflamm Res. 2014 Mar; 63(3):173-8. PMID: 24316865.
      View in: PubMed
    43. Kaplan A, Ledford D, Ashby M, Canvin J, Zazzali JL, Conner E, Veith J, Kamath N, Staubach P, Jakob T, Stirling RG, Kuna P, Berger W, Maurer M, Rosén K. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol. 2013 Jul; 132(1):101-9. PMID: 23810097.
      View in: PubMed
    44. Joseph K, Tholanikunnel TE, Kaplan AP. In vitro comparison of bradykinin degradation by aliskiren, a renin inhibitor, and an inhibitor of angiotensin-converting enzyme. J Renin Angiotensin Aldosterone Syst. 2015 Jun; 16(2):321-7. PMID: 23764715.
      View in: PubMed
    45. Joseph K, Tholanikunnel BG, Bygum A, Ghebrehiwet B, Kaplan AP. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II. J Allergy Clin Immunol. 2013 Aug; 132(2):470-5. PMID: 23672780.
      View in: PubMed
    46. Maurer M, Rosén K, Hsieh HJ, Saini S, Grattan C, Gimenéz-Arnau A, Agarwal S, Doyle R, Canvin J, Kaplan A, Casale T. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med. 2013 Mar 07; 368(10):924-35. PMID: 23432142.
      View in: PubMed
    47. Maurer M, Aberer W, Bouillet L, Caballero T, Fabien V, Kanny G, Kaplan A, Longhurst H, Zanichelli A. Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment. PLoS One. 2013; 8(2):e53773. PMID: 23390491.
      View in: PubMed
    48. Maurer M, Bindslev-Jensen C, Gimenez-Arnau A, Godse K, Grattan CE, Hide M, Kaplan AP, Makris M, Simons FE, Zhao Z, Zuberbier T, Church MK. Chronic idiopathic urticaria (CIU) is no longer idiopathic: time for an update. Br J Dermatol. 2013 Feb; 168(2):455-6. PMID: 22835147.
      View in: PubMed
    49. Zuraw BL, Bork K, Binkley KE, Banerji A, Christiansen SC, Castaldo A, Kaplan A, Riedl M, Kirkpatrick C, Magerl M, Drouet C, Cicardi M. Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel. Allergy Asthma Proc. 2012 Nov-Dec; 33 Suppl 1:S145-56. PMID: 23394603.
      View in: PubMed
    50. Sánchez-Borges M, Asero R, Ansotegui IJ, Baiardini I, Bernstein JA, Canonica GW, Gower R, Kahn DA, Kaplan AP, Katelaris C, Maurer M, Park HS, Potter P, Saini S, Tassinari P, Tedeschi A, Ye YM, Zuberbier T. Diagnosis and treatment of urticaria and angioedema: a worldwide perspective. World Allergy Organ J. 2012 Nov; 5(11):125-47. PMID: 23282382.
      View in: PubMed
    51. Kaplan A. Type III hereditary angioedema: defined, but not understood. Ann Allergy Asthma Immunol. 2012 Sep; 109(3):153-4. PMID: 22920066.
      View in: PubMed
    52. Kaplan AP. Biologic agents in the treatment of urticaria. Curr Allergy Asthma Rep. 2012 Aug; 12(4):288-91. PMID: 22740008.
      View in: PubMed
    53. Kaplan AP. Treatment of chronic spontaneous urticaria. Allergy Asthma Immunol Res. 2012 Nov; 4(6):326-31. PMID: 23115728.
      View in: PubMed
    54. Ghebrehiwet B, Jesty J, Xu S, Vinayagasundaram R, Vinayagasundaram U, Ji Y, Valentino A, Hosszu KK, Mathew S, Joseph K, Kaplan AP, Peerschke EI. Structure-function studies using deletion mutants identify domains of gC1qR/p33 as potential therapeutic targets for vascular permeability and inflammation. Front Immunol. 2011 Nov 01; 2. PMID: 22282702.
      View in: PubMed
    55. Kaplan AP. History of the World Allergy Organization: 1989 to 2006, the XVIII World Allergy Congress, Journal Development, Reorganization, and New Programs. World Allergy Organ J. 2011 Aug; 4(8):135-7. PMID: 23282542.
      View in: PubMed
    56. Saini S, Rosen KE, Hsieh HJ, Wong DA, Conner E, Kaplan A, Spector S, Maurer M. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. J Allergy Clin Immunol. 2011 Sep; 128(3):567-73.e1. PMID: 21762974.
      View in: PubMed
    57. Kaplan AP. What to do with refractory urticaria patients. Curr Allergy Asthma Rep. 2011 Jun; 11(3):189-91. PMID: 21431840.
      View in: PubMed
    58. Kaplan AP. Bradykinin and the pathogenesis of hereditary angioedema. World Allergy Organ J. 2011 Apr; 4(4):73-5. PMID: 23282402.
      View in: PubMed
    59. White WB, Bresalier R, Kaplan AP, Palmer BF, Riddell RH, Lesogor A, Chang W, Keefe DL. Safety and tolerability of the direct renin inhibitor aliskiren in combination with angiotensin receptor blockers and thiazide diuretics: a pooled analysis of clinical experience of 12,942 patients. J Clin Hypertens (Greenwich). 2011 Jul; 13(7):506-16. PMID: 21762364.
      View in: PubMed
    60. Ferrer M, Gamboa P, Sanz ML, Goikoetxea MJ, Cabrera-Freitag P, Javaloyes G, Berroa F, Kaplan AP. Omalizumab is effective in nonautoimmune urticaria. J Allergy Clin Immunol. 2011 May; 127(5):1300-2. PMID: 21315432.
      View in: PubMed
    61. Maurer M, Weller K, Bindslev-Jensen C, Giménez-Arnau A, Bousquet PJ, Bousquet J, Canonica GW, Church MK, Godse KV, Grattan CE, Greaves MW, Hide M, Kalogeromitros D, Kaplan AP, Saini SS, Zhu XJ, Zuberbier T. Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy. 2011 Mar; 66(3):317-30. PMID: 21083565.
      View in: PubMed
    62. Kaplan AP. Enzymatic pathways in the pathogenesis of hereditary angioedema: the role of C1 inhibitor therapy. J Allergy Clin Immunol. 2010 Nov; 126(5):918-25. PMID: 20889195.
      View in: PubMed
    63. White WB, Bresalier R, Kaplan AP, Palmer BF, Riddell RH, Lesogor A, Chang W, Keefe DL. Safety and tolerability of the direct renin inhibitor aliskiren: a pooled analysis of clinical experience in more than 12,000 patients with hypertension. J Clin Hypertens (Greenwich). 2010 Oct; 12(10):765-75. PMID: 21029339.
      View in: PubMed
    64. Kaplan AP, Ghebrehiwet B. The plasma bradykinin-forming pathways and its interrelationships with complement. Mol Immunol. 2010 Aug; 47(13):2161-9. PMID: 20580091.
      View in: PubMed
    65. Mathias SD, Dreskin SC, Kaplan A, Saini SS, Spector S, Rosén KE. Development of a daily diary for patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 2010 Aug; 105(2):142-8. PMID: 20674825.
      View in: PubMed
    66. Kaplan AP. Dietary therapy for chronic urticaria. Curr Allergy Asthma Rep. 2010 Jul; 10(4):225-6. PMID: 20425001.
      View in: PubMed
    67. Kaplan AP. Treatment of cold urticaria. Curr Allergy Asthma Rep. 2010 Jul; 10(4):223-4. PMID: 20425002.
      View in: PubMed
    68. Fukuda Y, Berry TL, Nelson M, Hunter CL, Fukuhara K, Imai H, Ito S, Granholm-Bentley AC, Kaplan AP, Mutoh T. Stimulated neuronal expression of brain-derived neurotrophic factor by Neurotropin. Mol Cell Neurosci. 2010 Nov; 45(3):226-33. PMID: 20600926.
      View in: PubMed
    69. Kaplan AP. Kinins, airway obstruction, and anaphylaxis. Chem Immunol Allergy. 2010; 95:67-84. PMID: 20519882.
      View in: PubMed
    70. Kaplan AP, Joseph K. Kinin formation in C1 inhibitor deficiency. J Allergy Clin Immunol. 2010 Jun; 125(6):1411-2; author reply 1412. PMID: 20381848.
      View in: PubMed
    71. Kaplan AP, Joseph K. The bradykinin-forming cascade and its role in hereditary angioedema. Ann Allergy Asthma Immunol. 2010 Mar; 104(3):193-204. PMID: 20377108.
      View in: PubMed
    72. Joseph K, Tholanikunnel TE, Kaplan AP. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis. Ann Allergy Asthma Immunol. 2010 Jan; 104(1):50-4. PMID: 20143645.
      View in: PubMed
    73. Kaplan AP, Greaves M. Pathogenesis of chronic urticaria. Clin Exp Allergy. 2009 Jun; 39(6):777-87. PMID: 19400905.
      View in: PubMed
    74. Joseph K, Tholanikunnel BG, Kaplan AP. Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor. J Allergy Clin Immunol. 2009 Jul; 124(1):143-9. PMID: 19342086.
      View in: PubMed
    75. Kaplan AP. What the first 10,000 patients with chronic urticaria have taught me: a personal journey. J Allergy Clin Immunol. 2009 Mar; 123(3):713-7. PMID: 19081615.
      View in: PubMed
    76. Kaplan AP, Joseph K, Maykut RJ, Geba GP, Zeldin RK. Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol. 2008 Sep; 122(3):569-73. PMID: 18774392.
      View in: PubMed
    77. Joseph K, Tuscano TB, Kaplan AP. Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma. Ann Allergy Asthma Immunol. 2008 Sep; 101(3):279-86. PMID: 18814451.
      View in: PubMed
    78. Kaplan AP. Angioedema. World Allergy Organ J. 2008 Jun; 1(6):103-13. PMID: 23282406.
      View in: PubMed
    79. Kaplan AP, Joseph K. Basophil secretion in chronic urticaria: autoantibody-dependent or not? J Allergy Clin Immunol. 2007 Sep; 120(3):729-30. PMID: 17604092.
      View in: PubMed
    80. Ferrer M, Kaplan AP. Progress and challenges in the understanding of chronic urticaria. Allergy Asthma Clin Immunol. 2007 Mar 15; 3(1):31-5. PMID: 20525151.
      View in: PubMed
    81. Ferrer M, Kaplan AP. Chronic urticaria: what is new, where are we headed. Allergol Immunopathol (Madr). 2007 Mar-Apr; 35(2):57-61. PMID: 17428401.
      View in: PubMed
    82. Woodworth BA, Neal JG, Newton D, Joseph K, Kaplan AP, Baatz JE, Schlosser RJ. Surfactant protein A and D in human sinus mucosa: a preliminary report. ORL J Otorhinolaryngol Relat Spec. 2007; 69(1):57-60. PMID: 17085954.
      View in: PubMed
    83. Heidecker J, Kaplan A, Sahn SA. Pleural fluid and peripheral eosinophilia from hemothorax: hypothesis of the pathogenesis of EPE in hemothorax and pneumothorax. Am J Med Sci. 2006 Sep; 332(3):148-52. PMID: 16969147.
      View in: PubMed
    84. Kaplan AP, Greaves MW. Angioedema. J Am Acad Dermatol. 2005 Sep; 53(3):373-88; quiz 389-92. PMID: 16112343.
      View in: PubMed
    85. Kostis JB, Kim HJ, Rusnak J, Casale T, Kaplan A, Corren J, Levy E. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med. 2005 Jul 25; 165(14):1637-42. PMID: 16043683.
      View in: PubMed
    86. Fernando AN, Fernando LP, Fukuda Y, Kaplan AP. Assembly, activation, and signaling by kinin-forming proteins on human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2005 Jul; 289(1):H251-7. PMID: 15961376.
      View in: PubMed
    87. Kaplan AP, Spector SL, Meeves S, Liao Y, Varghese ST, Georges G. Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. Ann Allergy Asthma Immunol. 2005 Jun; 94(6):662-9. PMID: 15984599.
      View in: PubMed
    88. Marsland AM, Soundararajan S, Joseph K, Kaplan AP. Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria. Clin Exp Allergy. 2005 May; 35(5):554-9. PMID: 15898974.
      View in: PubMed
    89. Luquin E, Kaplan AP, Ferrer M. Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli. Clin Exp Allergy. 2005 Apr; 35(4):456-60. PMID: 15836753.
      View in: PubMed
    90. Soundararajan S, Kikuchi Y, Joseph K, Kaplan AP. Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria. J Allergy Clin Immunol. 2005 Apr; 115(4):815-21. PMID: 15806004.
      View in: PubMed
    91. Kaplan AP, Ghebrehiwet B. Does C-2 kinin exist? J Allergy Clin Immunol. 2005 Apr; 115(4):876. PMID: 15806016.
      View in: PubMed
    92. Sampson HA, Muñoz-Furlong A, Bock SA, Schmitt C, Bass R, Chowdhury BA, Decker WW, Furlong TJ, Galli SJ, Golden DB, Gruchalla RS, Harlor AD, Hepner DL, Howarth M, Kaplan AP, Levy JH, Lewis LM, Lieberman PL, Metcalfe DD, Murphy R, Pollart SM, Pumphrey RS, Rosenwasser LJ, Simons FE, Wood JP, Camargo CA. Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol. 2005 Mar; 115(3):584-91. PMID: 15753908.
      View in: PubMed
    93. Kaplan AP. A new mechanism for immunologic initiation of asthma. Proc Natl Acad Sci U S A. 2005 Feb 01; 102(5):1267-8. PMID: 15677319.
      View in: PubMed
    94. Joseph K, Kaplan AP. Formation of bradykinin: a major contributor to the innate inflammatory response. Adv Immunol. 2005; 86:159-208. PMID: 15705422.
      View in: PubMed
    95. Kaplan AP. Comments regarding 'Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells' by Asero et al. A.P. Kaplan. Clin Exp Allergy. 2004 Nov; 34(11):1803; author reply 1804-5. PMID: 15544609.
      View in: PubMed
    96. Woodworth BA, Joseph K, Kaplan AP, Schlosser RJ. Alterations in eotaxin, monocyte chemoattractant protein-4, interleukin-5, and interleukin-13 after systemic steroid treatment for nasal polyps. Otolaryngol Head Neck Surg. 2004 Nov; 131(5):585-9. PMID: 15523430.
      View in: PubMed
    97. Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol. 2004 Sep; 114(3):465-74; quiz 475. PMID: 15356542.
      View in: PubMed
    98. Huggins JT, Kaplan A, Martin-Harris B, Sahn SA. Eucalyptus as a specific irritant causing vocal cord dysfunction. Ann Allergy Asthma Immunol. 2004 Sep; 93(3):299-303. PMID: 15478393.
      View in: PubMed
    99. Asher I, Baena-Cagnani C, Boner A, Canonica GW, Chuchalin A, Custovic A, Dagli E, Haahtela T, Haus M, Lemmo-Hoten M, Holgate S, Holloway J, Holt P, Host A, Iikura Y, Johansson SG, Kaplan A, Kowalski ML, Lockey RF, Naspitz C, Odhiambo J, Ring J, Sastre J, Venables K, Vichyanond P, Volovitz B, Wahn U, Warner J, Weiss K, Zhong NS. World Allergy Organization guidelines for prevention of allergy and allergic asthma. Int Arch Allergy Immunol. 2004 Sep; 135(1):83-92. PMID: 15452918.
      View in: PubMed
    100. Li HP, Li X, He GJ, Yi XH, Kaplan AP. The influence of dexamethasone on the proliferation and apoptosis of pulmonary inflammatory cells in bleomycin-induced pulmonary fibrosis in rats. Respirology. 2004 Mar; 9(1):25-32. PMID: 14982598.
      View in: PubMed
    101. Joseph K, Tholanikunnel BG, Ghebrehiwet B, Kaplan AP. Interaction of high molecular weight kininogen binding proteins on endothelial cells. Thromb Haemost. 2004 Jan; 91(1):61-70. PMID: 14691569.
      View in: PubMed
    102. Fernando LP, Natesan S, Joseph K, Kaplan AP. High molecular weight kininogen and factor XII binding to endothelial cells and astrocytes. Thromb Haemost. 2003 Nov; 90(5):787-95. PMID: 14597972.
      View in: PubMed
    103. Fernando LP, Fernando AN, Joseph K, Kaplan AP. Assessment of the role of heparan sulfate in high molecular weight kininogen binding to human umbilical vein endothelial cells. J Thromb Haemost. 2003 Nov; 1(11):2444-9. PMID: 14629481.
      View in: PubMed
    104. Ferrer M, Luquin E, Kaplan AP. IL3 effect on basophils histamine release upon stimulation with chronic urticaria sera. Allergy. 2003 Aug; 58(8):802-7. PMID: 12859562.
      View in: PubMed
    105. Kikuchi Y, Fann T, Kaplan AP. Antithyroid antibodies in chronic urticaria and angioedema. J Allergy Clin Immunol. 2003 Jul; 112(1):218. PMID: 12847508.
      View in: PubMed
    106. Joseph K, Tholanikunnel BG, Kaplan AP. Activation of the bradykinin-forming cascade on endothelial cells: a role for heat shock protein 90. Int Immunopharmacol. 2002 Dec; 2(13-14):1851-9. PMID: 12489799.
      View in: PubMed
    107. Nakazawa Y, Joseph K, Kaplan AP. Inhibition of contact activation by a kininogen peptide (HKH20) derived from domain 5. Int Immunopharmacol. 2002 Dec; 2(13-14):1875-85. PMID: 12494915.
      View in: PubMed
    108. Ferrer M, Luquin E, Sanchez-Ibarrola A, Moreno C, Sanz ML, Kaplan AP. Secretion of cytokines, histamine and leukotrienes in chronic urticaria. Int Arch Allergy Immunol. 2002 Nov; 129(3):254-60. PMID: 12444324.
      View in: PubMed
    109. Kaplan AP. Chronic urticaria--new concepts regarding pathogenesis and treatment. Curr Allergy Asthma Rep. 2002 Jul; 2(4):263-4. PMID: 12044258.
      View in: PubMed
    110. Ying S, Kikuchi Y, Meng Q, Kay AB, Kaplan AP. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol. 2002 Apr; 109(4):694-700. PMID: 11941321.
      View in: PubMed
    111. Abelson MB, Kaplan AP. A randomized, double-blind, placebo-controlled comparison of emedastine 0.05% ophthalmic solution with loratadine 10 mg and their combination in the human conjunctival allergen challenge model. Clin Ther. 2002 Mar; 24(3):445-56. PMID: 11952027.
      View in: PubMed
    112. Kaplan AP, Joseph K, Silverberg M. Pathways for bradykinin formation and inflammatory disease. J Allergy Clin Immunol. 2002 Feb; 109(2):195-209. PMID: 11842287.
      View in: PubMed
    113. Kaplan AP. Clinical practice. Chronic urticaria and angioedema. N Engl J Med. 2002 Jan 17; 346(3):175-9. PMID: 11796852.
      View in: PubMed
    114. Joseph K, Tholanikunnel BG, Kaplan AP. Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII. Proc Natl Acad Sci U S A. 2002 Jan 22; 99(2):896-900. PMID: 11792853.
      View in: PubMed
    115. Kikuchi Y, Kaplan AP. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol. 2002 Jan; 109(1):114-8. PMID: 11799375.
      View in: PubMed
    116. Commins SP, Kaplan AP. Immediate pressure urticaria. Allergy. 2002 Jan; 57(1):56-7. PMID: 11991295.
      View in: PubMed
    117. Haselden BM, Larché M, Meng Q, Shirley K, Dworski R, Kaplan AP, Bates C, Robinson DS, Ying S, Kay AB. Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or T(H)2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalveolar fluid. J Allergy Clin Immunol. 2001 Sep; 108(3):394-401. PMID: 11544459.
      View in: PubMed
    118. Kikuchi Y, Kaplan AP. Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol. 2001 Jun; 107(6):1056-62. PMID: 11398085.
      View in: PubMed
    119. Kaplan AP. Chemokines, chemokine receptors and allergy. Int Arch Allergy Immunol. 2001 Apr; 124(4):423-31. PMID: 11340325.
      View in: PubMed
    120. Kaplan AP, Joseph K, Shibayama Y, Reddigari S, Ghebrehiwet B. Activation of the plasma kinin forming cascade along cell surfaces. Int Arch Allergy Immunol. 2001 Jan-Mar; 124(1-3):339-42. PMID: 11307009.
      View in: PubMed
    121. Kaplan AP. C1 inhibitor deficiency: hereditary and acquired forms. J Investig Allergol Clin Immunol. 2001; 11(4):211-9. PMID: 11908809.
      View in: PubMed
    122. Joseph K, Shibayama Y, Ghebrehiwet B, Kaplan AP. Factor XII-dependent contact activation on endothelial cells and binding proteins gC1qR and cytokeratin 1. Thromb Haemost. 2001 Jan; 85(1):119-24. PMID: 11204562.
      View in: PubMed
    123. Joseph K, Ghebrehiwet B, Kaplan AP. Activation of the kinin-forming cascade on the surface of endothelial cells. Biol Chem. 2001 Jan; 382(1):71-5. PMID: 11258676.
      View in: PubMed
    124. Kaplan AP. Acquired C1 esterase inhibitor deficiency. Ann Intern Med. 2000 Nov 21; 133(10):838; author reply 839. PMID: 11085853.
      View in: PubMed
    125. Kaplan AP. Diagnostic tests for urticaria and angioedema. Clin Allergy Immunol. 2000; 15:111-26. PMID: 10943290.
      View in: PubMed
    126. Kaplan AP, Finn A. Pathogenesis and treatment of chronic urticaria. Postgrad Med. 1999 Dec; 106(7 Suppl):12-7. PMID: 19667496.
      View in: PubMed
    127. Finn AF, Kaplan AP, Fretwell R, Qu R, Long J. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol. 1999 Nov; 104(5):1071-8. PMID: 10550755.
      View in: PubMed
    128. Joseph K, Shibayama Y, Nakazawa Y, Peerschke EI, Ghebrehiwet B, Kaplan AP. Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Abeta protein of Alzheimer's disease. Immunopharmacology. 1999 Sep; 43(2-3):203-10. PMID: 10596854.
      View in: PubMed
    129. Joseph K, Ghebrehiwet B, Kaplan AP. Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells. Clin Immunol. 1999 Sep; 92(3):246-55. PMID: 10479529.
      View in: PubMed
    130. Joseph K, Nakazawa Y, Bahou WF, Ghebrehiwet B, Kaplan AP. Platelet glycoprotein Ib: a zinc-dependent binding protein for the heavy chain of high-molecular-weight kininogen. Mol Med. 1999 Aug; 5(8):555-63. PMID: 10501658.
      View in: PubMed
    131. Ferrer M, Nakazawa K, Kaplan AP. Complement dependence of histamine release in chronic urticaria. J Allergy Clin Immunol. 1999 Jul; 104(1):169-72. PMID: 10400855.
      View in: PubMed
    132. Shibayama Y, Joseph K, Nakazawa Y, Ghebreihiwet B, Peerschke EI, Kaplan AP. Zinc-dependent activation of the plasma kinin-forming cascade by aggregated beta amyloid protein. Clin Immunol. 1999 Jan; 90(1):89-99. PMID: 9884356.
      View in: PubMed
    133. Kaplan AP. An IgE-dependent histamine-releasing factor (HRF) identical to a previously described human protein (P23) Allergy. 1998 Jul; 53(7):631-2. PMID: 9700031.
      View in: PubMed
    134. Ferrer M, Kinét JP, Kaplan AP. Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RIalpha (alpha-subunit) in chronic urticaria. J Allergy Clin Immunol. 1998 May; 101(5):672-6. PMID: 9600505.
      View in: PubMed
    135. Shibayama Y, Reddigari SR, Teruya M, Nakamura K, Fukunaga Y, Ienaga K, Nishikawa K, Suehiro S, Kaplan AP. Effect of neurotropin on the binding of high molecular weight kininogen and Hageman factor to human umbilical vein endothelial cells and the autoactivation of bound Hageman factor. Biochem Pharmacol. 1998 Apr 15; 55(8):1175-80. PMID: 9719471.
      View in: PubMed
    136. Kaplan AP, Kuna P. Chemokines and the late-phase reaction. Allergy. 1998; 53(45 Suppl):27-32. PMID: 9788704.
      View in: PubMed
    137. Kaplan AP, Joseph K, Shibayama Y, Nakazawa Y, Ghebrehiwet B, Reddigari S, Silverberg M. Bradykinin formation. Plasma and tissue pathways and cellular interactions. Clin Rev Allergy Immunol. 1998; 16(4):403-29. PMID: 9926288.
      View in: PubMed
    138. Zweiman B, Kaplan AP, Tong L, Moskovitz AR. Cytokine levels and inflammatory responses in developing late-phase allergic reactions in the skin. J Allergy Clin Immunol. 1997 Jul; 100(1):104-9. PMID: 9257794.
      View in: PubMed
    139. Kaplan AP, Joseph K, Shibayama Y. Binding of activation of kinin-forming proteins on vascular endothelial cells. Immunopharmacology. 1997 Jun; 36(2-3):201-7. PMID: 9228547.
      View in: PubMed
    140. Brunnée T, Reddigari SR, Shibayama Y, Kaplan AP, Silverberg M. Mast cell derived heparin activates the contact system: a link to kinin generation in allergic reactions. Clin Exp Allergy. 1997 Jun; 27(6):653-63. PMID: 9208186.
      View in: PubMed
    141. Tong LJ, Balakrishnan G, Kochan JP, Kinét JP, Kaplan AP. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol. 1997 Apr; 99(4):461-5. PMID: 9111489.
      View in: PubMed
    142. Kaplan AP, Joseph K, Shibayama Y, Reddigari S, Ghebrehiwet B, Silverberg M. The intrinsic coagulation/kinin-forming cascade: assembly in plasma and cell surfaces in inflammation. Adv Immunol. 1997; 66:225-72. PMID: 9328643.
      View in: PubMed
    143. Kuna P, Iyer M, Peerschke EI, Kaplan AP, Reid KB, Ghebrehiwet B. Human C1q induces eosinophil migration. Clin Immunol Immunopathol. 1996 Oct; 81(1):48-54. PMID: 8808641.
      View in: PubMed
    144. Joseph K, Ghebrehiwet B, Peerschke EI, Reid KB, Kaplan AP. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R). Proc Natl Acad Sci U S A. 1996 Aug 06; 93(16):8552-7. PMID: 8710908.
      View in: PubMed
    145. Kuna P, Reddigari SR, Rucinski D, Kaplan AP. Further characterization of histamine releasing chemokines present in fractionated supernatants derived from human mononuclear cells. Clin Exp Allergy. 1996 Aug; 26(8):926-33. PMID: 8877158.
      View in: PubMed
    146. Shibayama Y, Skoner D, Suehiro S, Konishi JE, Fireman P, Kaplan AP. Bradykinin levels during experimental nasal infection with rhinovirus and attenuated influenza virus. Immunopharmacology. 1996 Jun; 33(1-3):311-3. PMID: 8856172.
      View in: PubMed
    147. Shibayama Y, Reddigari S, Kaplan AP. Interactions of factor XII with platelets and endothelial cells. Immunopharmacology. 1996 May; 32(1-3):24-7. PMID: 8796261.
      View in: PubMed
    148. Kaplan AP. Intrinsic coagulation, thrombosis, and bleeding. Blood. 1996 Mar 01; 87(5):2090. PMID: 8634463.
      View in: PubMed
    149. Doyle WJ, Skoner DP, White M, Hayden F, Kaplan AP, Kaliner MA, Shibayama Y, Fireman P. Pattern of nasal secretions during experimental influenza virus infection. Rhinology. 1996 Mar; 34(1):2-8. PMID: 8739859.
      View in: PubMed
    150. Kuna P, Lazarovich M, Kaplan AP. Chemokines in seasonal allergic rhinitis. J Allergy Clin Immunol. 1996 Jan; 97(1 Pt 1):104-12. PMID: 8568122.
      View in: PubMed
    151. Kuna P, Kaplan AP. Relationship of histamine-releasing factors and histamine-releasing inhibitory factors to chemokine group of cytokine. Allergy Asthma Proc. 1996 Jan-Feb; 17(1):5-11. PMID: 8814942.
      View in: PubMed
    152. Okayama Y, Brzezinska-Blaszczyk E, Kuna P, Kaplan AP, Church MK. Effects of PBMC-derived histamine-releasing factors on histamine release from human skin and lung mast cells. Clin Exp Allergy. 1995 Sep; 25(9):890-5. PMID: 8564728.
      View in: PubMed
    153. Kaplan AP, Kuna P, Reddigari SR. Chemokines and the allergic response. Exp Dermatol. 1995 Aug; 4(4 Pt 2):260-5. PMID: 8528599.
      View in: PubMed
    154. Reddigari S, Silverberg M, Kaplan AP. Assembly of the human plasma kinin-forming cascade along the surface of vascular endothelial cells. Int Arch Allergy Immunol. 1995 May-Jun; 107(1-3):93-4. PMID: 7613224.
      View in: PubMed
    155. Kuna P, Reddigari SR, Rucinski D, Schall TJ, Kaplan AP. Chemokines of the alpha, beta-subclass inhibit human basophils' responsiveness to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. J Allergy Clin Immunol. 1995 Feb; 95(2):574-86. PMID: 7531729.
      View in: PubMed
    156. Kaplan AP, Kuna P, Reddigari SR. Chemokines as allergic mediators--relationship to histamine-releasing factors. Allergy. 1994 Aug; 49(7):495-501. PMID: 7529967.
      View in: PubMed
    157. Shibayama Y, Brunnee T, Kaplan AP, Reddigari S. Activation of human Hageman factor (factor XII) in the presence of zinc and phosphate ions. Braz J Med Biol Res. 1994 Aug; 27(8):1817-28. PMID: 7749371.
      View in: PubMed
    158. Reddigari SR, Shibayama Y, Brunnée T, Kaplan AP. Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells. J Biol Chem. 1993 Jun 05; 268(16):11982-7. PMID: 8505323.
      View in: PubMed
    159. Kuna P, Reddigari SR, Schall TJ, Rucinski D, Sadick M, Kaplan AP. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family. J Immunol. 1993 Mar 01; 150(5):1932-43. PMID: 7679699.
      View in: PubMed
    160. Reddigari SR, Kuna P, Miragliotta G, Shibayama Y, Nishikawa K, Kaplan AP. Human high molecular weight kininogen binds to human umbilical vein endothelial cells via its heavy and light chains. Blood. 1993 Mar 01; 81(5):1306-11. PMID: 8443392.
      View in: PubMed
    161. Schulman G, Hakim R, Arias R, Silverberg M, Kaplan AP, Arbeit L. Bradykinin generation by dialysis membranes: possible role in anaphylactic reaction. J Am Soc Nephrol. 1993 Mar; 3(9):1563-9. PMID: 8507811.
      View in: PubMed
    162. Brunnée T, La Porta C, Reddigari SR, Salerno VM, Kaplan AP, Silverberg M. Activation of factor XI in plasma is dependent on factor XII. Blood. 1993 Feb 01; 81(3):580-6. PMID: 8427954.
      View in: PubMed
    163. Nishikawa K, Shibayama Y, Kuna P, Calcaterra E, Kaplan AP, Reddigari SR. Generation of vasoactive peptide bradykinin from human umbilical vein endothelium-bound high molecular weight kininogen by plasma kallikrein. Blood. 1992 Oct 15; 80(8):1980-8. PMID: 1391955.
      View in: PubMed
    164. Kuna P, Reddigari SR, Schall TJ, Rucinski D, Viksman MY, Kaplan AP. RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. J Immunol. 1992 Jul 15; 149(2):636-42. PMID: 1378073.
      View in: PubMed
    165. Nishikawa K, Reddigari SR, Silverberg M, Kuna PB, Yago H, Nagaki Y, Toyomaki Y, Suehiro S, Kaplan AP. Effect of Neurotropin on the activation of the plasma kallikrein-kinin system. Biochem Pharmacol. 1992 Mar 17; 43(6):1361-9. PMID: 1562287.
      View in: PubMed
    166. Reddigari SR, Kuna P, Miragliotta GF, Kornfeld D, Baeza ML, Castor CW, Kaplan AP. Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils. J Allergy Clin Immunol. 1992 Mar; 89(3):666-72. PMID: 1372016.
      View in: PubMed
    167. Kuna P, Reddigari SR, Rucinski D, Oppenheim JJ, Kaplan AP. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J Exp Med. 1992 Feb 01; 175(2):489-93. PMID: 1370686.
      View in: PubMed
    168. Haak-Frendscho M, Kaplan AP. Cytokine stimulation of human basophil histamine release. Immunol Ser. 1992; 57:573-86. PMID: 1380307.
      View in: PubMed
    169. Kaplan AP, Reddigari S, Brunnée T, Nishikawa K, Kuna P, Silverberg M. Studies of the activation and inhibition of the plasma kallikrein-kinin system. Agents Actions Suppl. 1992; 38 ( Pt 3):317-28. PMID: 1462866.
      View in: PubMed
    170. Kuna P, Reddigari SR, Kornfeld D, Kaplan AP. IL-8 inhibits histamine release from human basophils induced by histamine-releasing factors, connective tissue activating peptide III, and IL-3. J Immunol. 1991 Sep 15; 147(6):1920-4. PMID: 1716285.
      View in: PubMed
    171. Skriver K, Wikoff WR, Patston PA, Tausk F, Schapira M, Kaplan AP, Bock SC. Substrate properties of C1 inhibitor Ma (alanine 434----glutamic acid). Genetic and structural evidence suggesting that the P12-region contains critical determinants of serine protease inhibitor/substrate status. J Biol Chem. 1991 May 15; 266(14):9216-21. PMID: 2026621.
      View in: PubMed
    172. Kaplan AP, Baeza M, Reddigari S, Kuna P. Histamine-releasing factors. Int Arch Allergy Appl Immunol. 1991; 94(1-4):148-53. PMID: 1718884.
      View in: PubMed
    173. Kaplan AP, Baeza M, Reddigari S, Kuna P. Histamine releasing factors. Clin Exp Allergy. 1991 Jan; 21 Suppl 1:8-16. PMID: 1709584.
      View in: PubMed
    174. Kaplan AP, Reddigari S, Baeza M, Kuna P. Histamine releasing factors and cytokine-dependent activation of basophils and mast cells. Adv Immunol. 1991; 50:237-60. PMID: 1719781.
      View in: PubMed
    175. Gardella JE, Ghiso J, Gorgone GA, Marratta D, Kaplan AP, Frangione B, Gorevic PD. Intact Alzheimer amyloid precursor protein (APP) is present in platelet membranes and is encoded by platelet mRNA. Biochem Biophys Res Commun. 1990 Dec 31; 173(3):1292-8. PMID: 1702629.
      View in: PubMed
    176. Kurtz AS, Kaplan AP. Regional expression of cold urticaria. J Allergy Clin Immunol. 1990 Aug; 86(2):272-3. PMID: 2384655.
      View in: PubMed
    177. Baeza ML, Reddigari SR, Kornfeld D, Ramani N, Smith EM, Hossler PA, Fischer T, Castor CW, Gorevic PG, Kaplan AP. Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III. J Clin Invest. 1990 May; 85(5):1516-21. PMID: 1692035.
      View in: PubMed
    178. Kaplan AP. Urticaria: the relationship of duration of lesion to pathogenesis. Allergy Proc. 1990 Jan-Feb; 11(1):15-8. PMID: 2179056.
      View in: PubMed
    179. Reddigari SR, Kaplan AP. Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity. Blood. 1989 Aug 01; 74(2):695-702. PMID: 2752143.
      View in: PubMed
    180. Kaplan AP, Anderson JA, Valentine MD, Lockey RF, Pierson WE, Zweiman B, Kaliner MA, Lichtenstein LM, Lieberman PL, Settipane GA, et al. Beta-adrenergic blockers, immunotherapy, and skin testing. American Academy of Allergy and Immunology. J Allergy Clin Immunol. 1989 Jul; 84(1):129-30. PMID: 2569002.
      View in: PubMed
    181. Meier HL, Schulman ES, Heck LW, MacGlashan D, Newball HH, Kaplan AP. Release of elastase from purified human lung mast cells and basophils. Identification as a Hageman factor cleaving enzyme. Inflammation. 1989 Jun; 13(3):295-308. PMID: 2787784.
      View in: PubMed
    182. Reddigari S, Kaplan AP. Quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody. J Immunol Methods. 1989 Apr 21; 119(1):19-25. PMID: 2651524.
      View in: PubMed
    183. Baeza ML, Reddigari S, Haak-Frendscho M, Kaplan AP. Purification and further characterization of human mononuclear cell histamine-releasing factor. J Clin Invest. 1989 Apr; 83(4):1204-10. PMID: 2467921.
      View in: PubMed
    184. Sheikh IA, Kaplan AP. Mechanism of digestion of bradykinin and lysylbradykinin (kallidin) in human serum. Role of carboxypeptidase, angiotensin-converting enzyme and determination of final degradation products. Biochem Pharmacol. 1989 Mar 15; 38(6):993-1000. PMID: 2539165.
      View in: PubMed
    185. Kaplan AP. Relationship of Hageman factor activation to the formation of bradykinin in humans: a historical perspective. Prog Clin Biol Res. 1989; 297:311-23. PMID: 2685825.
      View in: PubMed
    186. Kaplan AP, Silverberg M, Ghebrehiwet B, Atkins P, Zweiman B. Pathways of kinin formation and role in allergic diseases. Clin Immunol Immunopathol. 1989 Jan; 50(1 Pt 2):S41-51. PMID: 2910589.
      View in: PubMed
    187. Reddigari S, Kaplan AP. Studies of the cleavage of human high molecular weight kininogen by purified plasma and tissue kallikreins, and upon contact activation of plasma. Adv Exp Med Biol. 1989; 247B:317-24. PMID: 2481945.
      View in: PubMed
    188. Kaplan AP, Silverberg M, Ghebrehiwet B, Atkins P, Zweiman B. The kallikrein-kinin system in inflammation. Adv Exp Med Biol. 1989; 247A:125-36. PMID: 2603786.
      View in: PubMed
    189. Randazzo BP, Fleit HB, Kaplan AP, Ghebrehiwet B. Expression of functional cell surface C1-inactivator by U937 cells. Clin Immunol Immunopathol. 1988 Dec; 49(3):463-77. PMID: 3191617.
      View in: PubMed
    190. White MV, Kaplan AP, Haak-Frendscho M, Kaliner M. Neutrophils and mast cells. Comparison of neutrophil-derived histamine-releasing activity with other histamine-releasing factors. J Immunol. 1988 Nov 15; 141(10):3575-83. PMID: 2460539.
      View in: PubMed
    191. Casale TB, Sampson HA, Hanifin J, Kaplan AP, Kulczycki A, Lawrence ID, Lemanske RF, Levine MI, Lillie MA. Guide to physical urticarias. J Allergy Clin Immunol. 1988 Nov; 82(5 Pt 1):758-63. PMID: 3057040.
      View in: PubMed
    192. Baeza ML, Haak-Frendscho M, Satnick S, Kaplan AP. Responsiveness to human mononuclear cell-derived histamine-releasing factor. Studies of allergic status and the role of IgE. J Immunol. 1988 Oct 15; 141(8):2688-92. PMID: 2459222.
      View in: PubMed
    193. Haak-Frendscho M, Dinarello C, Kaplan AP. Recombinant human interleukin-1 beta causes histamine release from human basophils. J Allergy Clin Immunol. 1988 Aug; 82(2):218-23. PMID: 3261306.
      View in: PubMed
    194. Gruber BL, Kaufman LD, Marchese MJ, Roth W, Kaplan AP. Anti-IgE autoantibodies in systemic lupus erythematosus. Prevalence and biologic activity. Arthritis Rheum. 1988 Aug; 31(8):1000-6. PMID: 3408506.
      View in: PubMed
    195. Haak-Frendscho M, Arai N, Arai K, Baeza ML, Finn A, Kaplan AP. Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3 cause basophil histamine release. J Clin Invest. 1988 Jul; 82(1):17-20. PMID: 2455733.
      View in: PubMed
    196. Reddigari S, Kaplan AP. Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma. Blood. 1988 May; 71(5):1334-40. PMID: 2451949.
      View in: PubMed
    197. Sheffer AL, Lieberman PL, Aaronson DW, Anderson JA, Kaplan AP, Pierson WE, Ellis EF, Lichtenstein LM, Lockey RF, Salvaggio JE, et al. Measurement of circulating IgG and IgE food-immune complexes. J Allergy Clin Immunol. 1988 Apr; 81(4):758-60. PMID: 3356853.
      View in: PubMed
    198. Gruber BL, Baeza ML, Marchese MJ, Agnello V, Kaplan AP. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol. 1988 Feb; 90(2):213-7. PMID: 2448392.
      View in: PubMed
    199. Proud D, Kaplan AP. Kinin formation: mechanisms and role in inflammatory disorders. Annu Rev Immunol. 1988; 6:49-83. PMID: 3289575.
      View in: PubMed
    200. Silverberg M, Kaplan AP. Human Hageman factor and its fragments. Methods Enzymol. 1988; 163:68-80. PMID: 3237092.
      View in: PubMed
    201. Kaplan AP, Silverberg M. Mediators of inflammation: an overview. Methods Enzymol. 1988; 163:3-23. PMID: 3070297.
      View in: PubMed
    202. Silverberg M, Kaplan AP. Prekallikrein. Methods Enzymol. 1988; 163:85-95. PMID: 3237096.
      View in: PubMed
    203. Atkins PC, Miragliotta G, Talbot SF, Zweiman B, Kaplan AP. Activation of plasma Hageman factor and kallikrein in ongoing allergic reactions in the skin. J Immunol. 1987 Oct 15; 139(8):2744-8. PMID: 3655370.
      View in: PubMed
    204. Kaplan AP, Silverberg M. The coagulation-kinin pathway of human plasma. Blood. 1987 Jul; 70(1):1-15. PMID: 3297198.
      View in: PubMed
    205. Sheikh IA, Kaplan AP. Assessment of kininases in rheumatic diseases and the effect of therapeutic agents. Arthritis Rheum. 1987 Feb; 30(2):138-45. PMID: 3030335.
      View in: PubMed
    206. Silverberg M, Longo J, Kaplan AP. Study of the effect of high molecular weight kininogen upon the fluid-phase inactivation of kallikrein by C1 inhibitor. J Biol Chem. 1986 Nov 15; 261(32):14965-8. PMID: 3639874.
      View in: PubMed
    207. Elias J, Boss E, Kaplan AP. Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T-lymphocytes, monocytes, and mast cells. J Allergy Clin Immunol. 1986 Nov; 78(5 Pt 1):914-8. PMID: 3491100.
      View in: PubMed
    208. Grant JA, Lett-Brown MA, Warner JA, Plaut M, Lichtenstein LM, Haak-Frendscho M, Kaplan AP. Activation of basophils. Fed Proc. 1986 Oct; 45(11):2653-8. PMID: 2428673.
      View in: PubMed
    209. Gruber B, Poznansky M, Boss E, Partin J, Gorevic P, Kaplan AP. Characterization and functional studies of rheumatoid synovial mast cells. Activation by secretagogues, anti-IgE, and a histamine-releasing lymphokine. Arthritis Rheum. 1986 Aug; 29(8):944-55. PMID: 2427092.
      View in: PubMed
    210. Weiss R, Silverberg M, Kaplan AP. The effect of C1 inhibitor upon Hageman factor autoactivation. Blood. 1986 Jul; 68(1):239-43. PMID: 3487356.
      View in: PubMed
    211. Sheikh IA, Kaplan AP. Studies of the digestion of bradykinin, lysyl bradykinin, and kinin-degradation products by carboxypeptidases A, B, and N. Biochem Pharmacol. 1986 Jun 15; 35(12):1957-63. PMID: 3718539.
      View in: PubMed
    212. Sheikh IA, Kaplan AP. Studies of the digestion of bradykinin, Lys-bradykinin, and des-Arg9-bradykinin by angiotensin converting enzyme. Biochem Pharmacol. 1986 Jun 15; 35(12):1951-6. PMID: 3013204.
      View in: PubMed
    213. Meier HL, Flowers B, Silverberg M, Kaplan AP, Newball HH. The IgE-dependent release of a Hageman factor cleaving factor from human lung. Am J Pathol. 1986 Apr; 123(1):146-54. PMID: 3634571.
      View in: PubMed
    214. Kaplan AP, Silverberg M, Ghebrehiwet B. The intrinsic coagulation/kinin pathway--the classical complement pathway and their interactions. Adv Exp Med Biol. 1986; 198 Pt B:11-25. PMID: 3544721.
      View in: PubMed
    215. Messina MS, Perry R, Silverberg M, Kaplan AP, Smaldone GC. Quantitative assays of pharmacologic aerosols used in studying asthma. J Allergy Clin Immunol. 1985 Oct; 76(4):605-9. PMID: 3902937.
      View in: PubMed
    216. Kaplan AP, Gruber B, Harpel PC. Assessment of Hageman factor activation in human plasma: quantification of activated Hageman factor-C1 inactivator complexes by an enzyme-linked differential antibody immunosorbent assay. Blood. 1985 Sep; 66(3):636-41. PMID: 3875374.
      View in: PubMed
    217. Randazzo BP, Dattwyler RJ, Kaplan AP, Ghebrehiwet B. Synthesis of C1 inhibitor (C1-INA) by a human monocyte-like cell line, U937. J Immunol. 1985 Aug; 135(2):1313-9. PMID: 4008925.
      View in: PubMed
    218. Becker CG, Wagner M, Kaplan AP, Silverberg M, Grady RW, Liem H, Muller-Eberhard U. Activation of factor XII-dependent pathways in human plasma by hematin and protoporphyrin. J Clin Invest. 1985 Aug; 76(2):413-9. PMID: 4031058.
      View in: PubMed
    219. Harpel PC, Lewin MF, Kaplan AP. Distribution of plasma kallikrein between C-1 inactivator and alpha 2-macroglobulin in plasma utilizing a new assay for alpha 2-macroglobulin-kallikrein complexes. J Biol Chem. 1985 Apr 10; 260(7):4257-63. PMID: 2579948.
      View in: PubMed
    220. Kaplan AP, Sheikh I, Frendscho MH. Assessment of histamine release and kinin formation in man: identification of kinin degradation products and characterization of a lymphocyte-dependent histamine releasing factor. Int Arch Allergy Appl Immunol. 1985; 77(1-2):64-8. PMID: 2409028.
      View in: PubMed
    221. Kaplan AP. Drug-induced skin disease. J Allergy Clin Immunol. 1984 Oct; 74(4 Pt 2):573-9. PMID: 6238077.
      View in: PubMed
    222. Ghebrehiwet B, Randazzo BP, Kaplan AP. Studies of complement autoactivatability in hereditary angioedema: direct relationship to functional C-1-INA and the effect of classical pathway activators. Clin Immunol Immunopathol. 1984 Jul; 32(1):101-10. PMID: 6733980.
      View in: PubMed
    223. Kaplan AP. Exercise-induced hives. J Allergy Clin Immunol. 1984 May; 73(5 Pt 2):704-7. PMID: 6371106.
      View in: PubMed
    224. Shimamoto K, Mayfield RK, Margolius HS, Chao J, Stroud W, Kaplan AP. Immunoreactive tissue kallikrein in human serum. J Lab Clin Med. 1984 May; 103(5):731-8. PMID: 6562156.
      View in: PubMed
    225. Kaplan AP. Unusual cold-induced disorders: cold-dependent dermatographism and systemic cold urticaria. J Allergy Clin Immunol. 1984 Apr; 73(4):453-6. PMID: 6200525.
      View in: PubMed
    226. Petillo JJ, Natbony SF, Zisblatt M, Vukovich RA, Neiss ES, Kaplan AP. Preliminary report on the effects of tiaramide on the ice cube test in patients with idiopathic cold urticaria. Ann Allergy. 1983 Nov; 51(5):511-4. PMID: 6638614.
      View in: PubMed
    227. Kaplan AP. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation. Fed Proc. 1983 Nov; 42(14):3123-7. PMID: 6556144.
      View in: PubMed
    228. Kaplan AP. Chronic urticaria. Possible causes, suggested treatment alternatives. Postgrad Med. 1983 Sep; 74(3):209-15, 218-22. PMID: 6136955.
      View in: PubMed
    229. Fields T, Ghebrehiwet B, Kaplan AP. Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykinin. J Allergy Clin Immunol. 1983 Jul; 72(1):54-60. PMID: 6222104.
      View in: PubMed
    230. Lewin MF, Kaplan AP, Harpel PC. Studies of C1 inactivator-plasma kallikrein complexes in purified systems and in plasma. J Biol Chem. 1983 May 25; 258(10):6415-21. PMID: 6343376.
      View in: PubMed
    231. Ghebrehiwet B, Randazzo BP, Dunn JT, Silverberg M, Kaplan AP. Mechanisms of activation of the classical pathway of complement by Hageman factor fragment. J Clin Invest. 1983 May; 71(5):1450-6. PMID: 6304147.
      View in: PubMed
    232. Natbony SF, Phillips ME, Elias JM, Godfrey HP, Kaplan AP. Histologic studies of chronic idiopathic urticaria. J Allergy Clin Immunol. 1983 Feb; 71(2):177-83. PMID: 6822693.
      View in: PubMed
    233. Fields TR, Abramson SB, Weissmann G, Kaplan AP, Ghebrehiwet B. Activation of the alternative pathway of complement by monosodium urate crystals. Clin Immunol Immunopathol. 1983 Feb; 26(2):249-57. PMID: 6872344.
      View in: PubMed
    234. Kaplan AP, Dunn JT, Silverberg M. Initiation of contact activation of human plasma. Adv Exp Med Biol. 1983; 156:45-61. PMID: 6602463.
      View in: PubMed
    235. Kaplan AP. Mechanisms of bradykinin generation in human plasma. Monogr Allergy. 1983; 18:272-6. PMID: 6358866.
      View in: PubMed
    236. Silverberg M, Kaplan AP. Enzymatic activities of activated and zymogen forms of human Hageman factor (factor XII). Blood. 1982 Jul; 60(1):64-70. PMID: 6979361.
      View in: PubMed
    237. Dunn JT, Silverberg M, Kaplan AP. The cleavage and formation of activated human Hageman factor by autodigestion and by kallikrein. J Biol Chem. 1982 Feb 25; 257(4):1779-84. PMID: 6915937.
      View in: PubMed
    238. Kaplan AP, Silverberg M, Dunn JT, Ghebrehiwet B. Interaction of the clotting, kinin-forming, complement, and fibrinolytic pathways in inflammation. Ann N Y Acad Sci. 1982; 389:25-38. PMID: 7046578.
      View in: PubMed
    239. Kaplan AP, Garofalo J. Identification of a new physically induced urticaria: cold-induced cholinergic urticaria. J Allergy Clin Immunol. 1981 Dec; 68(6):438-41. PMID: 7310011.
      View in: PubMed
    240. Kaplan AP, Garofalo J, Sigler R, Hauber T. Idiopathic cold urticaria: in vitro demonstration of histamine release upon challenge of skin biopsies. N Engl J Med. 1981 Oct 29; 305(18):1074-7. PMID: 6168912.
      View in: PubMed
    241. Kaplan AP, Natbony SF, Tawil AP, Fruchter L, Foster M. Exercise-induced anaphylaxis as a manifestation of cholinergic urticaria. J Allergy Clin Immunol. 1981 Oct; 68(4):319-24. PMID: 6169753.
      View in: PubMed
    242. Kaplan AP, Ghebrehiwet B, Silverberg M, Sealey JE. The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships. Crit Rev Immunol. 1981 Sep; 3(1):75-93. PMID: 7047077.
      View in: PubMed
    243. Garafalo J, Kaplan AP. Histamine release and therapy of severe dermatographism. J Allergy Clin Immunol. 1981 Aug; 68(2):103-5. PMID: 6166647.
      View in: PubMed
    244. Blumberg AL, Sealey JE, Atlas SA, Laragh JH, Dharmgrongartama B, Kaplan AP. Contact activation of human plasma prorenin in vitro. J Lab Clin Med. 1981 Jun; 97(6):771-8. PMID: 7014741.
      View in: PubMed
    245. Kaplan AP. The pathogenic basis of urticaria and angioedema: recent advances. Am J Med. 1981 Apr; 70(4):755-8. PMID: 7211911.
      View in: PubMed
    246. Ghebrehiwet B, Silverberg M, Kaplan AP. Activation of the classical pathway of complement by Hageman factor fragment. J Exp Med. 1981 Mar 01; 153(3):665-76. PMID: 7252410.
      View in: PubMed
    247. Kaplan AP, Silverberg M, Dunn JT, Miller G. Mechanisms for Hageman factor activation and role of HMW kininogen as a coagulation cofactor. Ann N Y Acad Sci. 1981; 370:253-60. PMID: 6455951.
      View in: PubMed
    248. Silverberg M, Nicoll JE, Kaplan AP. The mechanism by which the light chain of cleaved HMW-kininogen augments the activation of prekallikrein, factor XI and Hageman factor. Thromb Res. 1980 Oct 15; 20(2):173-89. PMID: 6908319.
      View in: PubMed
    249. Gorevic PD, Kaplan AP. The physical urticarias. Int J Dermatol. 1980 Oct; 19(8):417-35. PMID: 6161901.
      View in: PubMed
    250. Silverberg M, Dunn JT, Garen L, Kaplan AP. Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate. J Biol Chem. 1980 Aug 10; 255(15):7281-6. PMID: 7391081.
      View in: PubMed
    251. Sigler RW, Evans R, Horakova Z, Ottesen E, Kaplan AP. The role of cyproheptadine in the treatment of cold urticaria. J Allergy Clin Immunol. 1980 Apr; 65(4):309-12. PMID: 6102102.
      View in: PubMed
    252. Miller G, Silverberg M, Kaplan AP. Autoactivatability of human Hageman factor (factor XII). Biochem Biophys Res Commun. 1980 Feb 12; 92(3):803-10. PMID: 7362605.
      View in: PubMed
    253. Sealey JE, Atlas SA, Laragh JH, Silverberg M, Kaplan AP. Plasmin can activate plasma prorenin but is not required for the alkaline phase of acid activation. Clin Sci (Lond). 1979 Dec; 57 Suppl 5:97s-99s. PMID: 44236.
      View in: PubMed
    254. Sealey JE, Atlas SA, Laragh JH, Silverberg M, Kaplan AP. Initiation of plasma prorenin activation by Hageman factor-dependent conversion of plasma prekallikrein to kallikrein. Proc Natl Acad Sci U S A. 1979 Nov; 76(11):5914-8. PMID: 42905.
      View in: PubMed
    255. Mandle RJ, Kaplan AP. Hageman-factor-dependent fibrinolysis: generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen. Blood. 1979 Oct; 54(4):850-62. PMID: 89876.
      View in: PubMed
    256. Thompson RE, Mandle R, Kaplan AP. Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain. Proc Natl Acad Sci U S A. 1979 Oct; 76(10):4862-6. PMID: 291905.
      View in: PubMed
    257. Gorevic P, Kaplan AP. Contrast agents and anaphylactic-like reactions. J Allergy Clin Immunol. 1979 Apr; 63(4):225-7. PMID: 429701.
      View in: PubMed
    258. Kaplan AP. Structure-function correlation of human kininogen. Monogr Allergy. 1979; 14:212-7. PMID: 503075.
      View in: PubMed
    259. Sigler RW, Levinson AI, Evans R, Horakova Z, Kaplan AP. Evaluation of a patient with cold and cholinergic urticaria. J Allergy Clin Immunol. 1979 Jan; 63(1):35-8. PMID: 82566.
      View in: PubMed
    260. Kaplan AP. The role of high molecular weight kininogen in contact activation of coagulation, fibrinolysis and kinin generation. Adv Exp Med Biol. 1979; 120B:71-91. PMID: 390992.
      View in: PubMed
    261. Kaplan AP, Horáková Z, Katz SI. Assessment of tissue fluid histamine levels in patients with urticaria. J Allergy Clin Immunol. 1978 Jun; 61(6):350-4. PMID: 659726.
      View in: PubMed
    262. Kaplan AP, Castellino FJ, Collen D, Wiman B, Taylor FB. Molecular mechanisms of fibrinolysis in man. Thromb Haemost. 1978 Apr 30; 39(2):263-83. PMID: 354080.
      View in: PubMed
    263. Thompson RE, Mandle R, Kaplan AP. Characterization of human high molecular weight kininogen. Procoagulant activity associated with the light chain of kinin-free high molecular weight kininogen. J Exp Med. 1978 Feb 01; 147(2):488-99. PMID: 75240.
      View in: PubMed
    264. Kaplan AP. Initiation of the intrinsic coagulation and fibrinolytic pathways of man: the role of surfaces, hageman factor, prekallikrein, high molecular weight kininogen, and factor XI. Prog Hemost Thromb. 1978; 4:127-75. PMID: 362477.
      View in: PubMed
    265. Thompson RE, Mandle R, Kaplan AP. Association of factor XI and high molecular weight kininogen in human plasma. J Clin Invest. 1977 Dec; 60(6):1376-80. PMID: 915004.
      View in: PubMed
    266. Kaplan AP. Mediators of urticaria and angioedema. J Allergy Clin Immunol. 1977 Nov; 60(5):324-32. PMID: 144147.
      View in: PubMed
    267. Metcalfe DD, Gadek JE, Raphael GD, Frank MM, Kaplan AP, Kaliner M. Human eosinophil adherence to serum-treated sepharose: granule-associated enzyme release and requirement for activation of the alternative complement pathway. J Immunol. 1977 Nov; 119(5):1744-50. PMID: 915279.
      View in: PubMed
    268. Mandle R, Kaplan AP. Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis. J Biol Chem. 1977 Sep 10; 252(17):6097-104. PMID: 408348.
      View in: PubMed
    269. Meier HL, Pierce JV, Colman RW, Kaplan AP. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein. J Clin Invest. 1977 Jul; 60(1):18-31. PMID: 874082.
      View in: PubMed
    270. Liu CY, Scott CF, Bagdasarian A, Pierce JV, Kaplan AP, Colman RW. Potentiation of the function of Hageman factor fragments by high molecular weight kininogen. J Clin Invest. 1977 Jul; 60(1):7-17. PMID: 874091.
      View in: PubMed
    271. Kaplan AP, Meier HL, Mandle RJ. The role of Hageman factor, prekallifrein, and high molecular weight kininogen in the generation of bradykinin and the initiation of coagulation and fibrinolysis. Monogr Allergy. 1977; 12:120-30. PMID: 335210.
      View in: PubMed
    272. Clark RA, Gallin JI, Kaplan AP. Mediator release from basophil granulocytes in chronic myelogenous leukemia. J Allergy Clin Immunol. 1976 Dec; 58(6):623-34. PMID: 62774.
      View in: PubMed
    273. Stead N, Kaplan AP, Rosenberg RD. Inhibition of activated factor XII by antithrombin-heparin cofactor. J Biol Chem. 1976 Nov 10; 251(21):6481-8. PMID: 61963.
      View in: PubMed
    274. Mandle RJ, Colman RW, Kaplan AP. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. Proc Natl Acad Sci U S A. 1976 Nov; 73(11):4179-83. PMID: 1069308.
      View in: PubMed
    275. Kaplan AP, Meier HL, Mandle R. The Hageman factor dependent pathways of coagulation, fibrinolysis, and kinin-generation. Semin Thromb Hemost. 1976 Jul; 3(1):1-26. PMID: 139682.
      View in: PubMed
    276. Metzger WJ, Kaplan AP, Beaven MA, Irons JS, Patterson R. Hereditary vibratory angioedema: confirmation of histamine release in a type of physical hypersensitivity. J Allergy Clin Immunol. 1976 Jun; 57(6):605-8. PMID: 58881.
      View in: PubMed
    277. Webster ME, Guimaraes JA, Kaplan AP, Colman RW, Pierce JV. Activation of surface-bound Hageman factor: pre-eminent role of high molecular weight kininogen and evidence for a new factor. Adv Exp Med Biol. 1976; 70(00):285-99. PMID: 937135.
      View in: PubMed
    278. Kay AB, Kaplan AP. Chemotaxis and haemostasis. Br J Haematol. 1975 Dec; 31(4):417-22. PMID: 801790.
      View in: PubMed
    279. Kaplan AP, Austen KF. Activation and control mechanisms of Hageman factor-dependent pathways of coagulation, fibrinolysis, and kinin generation and their contribution to the inflammatory response. J Allergy Clin Immunol. 1975 Dec; 56(6):491-506. PMID: 1107395.
      View in: PubMed
    280. Colman RW, Bagdasarian A, Talamo RC, Scott CF, Seavey M, Guimaraes JA, Pierce JV, Kaplan AP. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. J Clin Invest. 1975 Dec; 56(6):1650-62. PMID: 1202089.
      View in: PubMed
    281. Kaplan AP, Gray L, Shaff RE, Horakova Z, Beaven MA. In vivo studies of mediator release in cold urticaria and cholinergic urticaria. J Allergy Clin Immunol. 1975 Jun; 55(6):394-402. PMID: 48522.
      View in: PubMed
    282. Heck LW, Kaplan AP. Substrates of Hageman factor. I. Isolation and characterization of human factor XI (PTA) and inhibition of the activated enzyme by alpha 1-antitrypsin. J Exp Med. 1974 Dec 01; 140(6):1615-30. PMID: 4547783.
      View in: PubMed
    283. Gallin JI, Kaplan AP. Mononuclear cell chemotactic activity of kallikrein and plasminogen activator and its inhibition by C1 inhibitor and alpha 2-macroglobulin. J Immunol. 1974 Dec; 113(6):1928-34. PMID: 4214866.
      View in: PubMed
    284. Kaplan AP. The Hageman factor dependent pathways of human plasma. Microvasc Res. 1974 Jul; 8(1):97-111. PMID: 4278345.
      View in: PubMed
    285. Weiss AS, Gallin JI, Kaplan AP. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation. J Clin Invest. 1974 Feb; 53(2):622-33. PMID: 11344577.
      View in: PubMed
    286. Kaplan AP, Goetzl EJ, Austen KF. The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator. J Clin Invest. 1973 Oct; 52(10):2591-5. PMID: 4729052.
      View in: PubMed
    287. Spragg J, Kaplan AP, Austen KF. The use of isoelectric focusing to study components of the human plasma kinin-forming system. Ann N Y Acad Sci. 1973 Jun 15; 209:372-86. PMID: 4515044.
      View in: PubMed
    288. Schreiber AD, Kaplan AP, Austen KF. Plasma inhibitors of the components of the fibrinolytic pathway in man. J Clin Invest. 1973 Jun; 52(6):1394-401. PMID: 4122174.
      View in: PubMed
    289. Schreiber AD, Kaplan AP, Austen KF. Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation. J Clin Invest. 1973 Jun; 52(6):1402-9. PMID: 4703226.
      View in: PubMed
    290. Kaplan AP, Austen KF. The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator. J Exp Med. 1972 Dec 01; 136(6):1378-93. PMID: 4264575.
      View in: PubMed
    291. Kaplan AP, Kay AB, Austen KF. A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein. J Exp Med. 1972 Jan; 135(1):81-97. PMID: 5009705.
      View in: PubMed
    292. Kaplan AP, Austen KF. A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin. J Exp Med. 1971 Apr 01; 133(4):696-712. PMID: 4251126.
      View in: PubMed
    Kaplan's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description